SLT is a popular treatment option for glaucoma. In this article, Dr McAlinden discusses his recent paper that reviewed comparative studies from peer-reviewed journals, finding encouraging and reassuring results about SLT.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.